1. Home
  2. MMA vs SNGX Comparison

MMA vs SNGX Comparison

Compare MMA & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MMA

Alta Global Group Limited

HOLD

Current Price

$0.43

Market Cap

12.2M

Sector

N/A

ML Signal

HOLD

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$1.14

Market Cap

11.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MMA
SNGX
Founded
2013
1987
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.2M
11.2M
IPO Year
2023
2006

Fundamental Metrics

Financial Performance
Metric
MMA
SNGX
Price
$0.43
$1.14
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
333.0K
179.3K
Earning Date
05-20-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.03
EPS
N/A
N/A
Revenue
N/A
$119,371.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.35
$1.00
52 Week High
$2.88
$6.23

Technical Indicators

Market Signals
Indicator
MMA
SNGX
Relative Strength Index (RSI) 40.25 43.82
Support Level $0.35 $1.01
Resistance Level $0.50 $1.47
Average True Range (ATR) 0.06 0.09
MACD 0.01 -0.01
Stochastic Oscillator 36.40 42.19

Price Performance

Historical Comparison
MMA
SNGX

About MMA Alta Global Group Limited

Mixed Martial Arts Group Ltd is a technology company operating in the martial arts and combat sports industry. The company operate four core business units: i) TrainAlta: A platform that transforms MMA fans into active participants through structured training programs like the Warrior Training Program, ii) BJJLink: A gym management platform designed for BJJ academies, offering tools for payment processing, marketing, student engagement, and content monetization, iii) Hype: A marketing platform helping gym owners, coaches, and athletes grow revenue from their audiences, iv) MixedMartialArts.com: The go-to resource for MMA news, fighter data, fight schedules, and the legendary Underground forum. Its majority of revenue is in the form of Program revenue, which consists of the license fees.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: